Press Release - Echosens

Choose your location

Choose your language

Validate

August 2025

Echosens and Novo Nordisk Advance Partnership to Increase Awareness and Early Diagnosis of MASH

July 2025

Echosens and United Digestive Partner to Expand Access to Non-Invasive Liver Diagnostics

June 2025

Echosens and Boehringer Ingelheim Expand Long-Standing Collaboration to Accelerate Progress in MASH Diagnosis and Care

November 2024

Echosens Launches its LHM Platform Globally, Streamlining Liver Care

November 2024

Meet the Inaugural Echosens Liver Health Super Shaper Award Recipients

August 2024

Echosens Announces the Liver Health Super Shaper Award to Honor Exceptional Medical Heroes

May 2024

Transforming Liver Health: Echosens Next-Generation FibroScan^® Now Available Worldwide

March 2024

Welcome Prof. Victor de Lédinghen MD PhD, Our New Chief Medical Officer at Echosens

March 2023

FDA Expands Indications for Use of FibroScan^® for Comprehensive Liver Management

February 2023

New AASLD Practice Guidance Calls for the Use of Noninvasive Liver Evaluations for Earlier Detection of NAFLD and NASH

Country*
Email*
By subscribing, I agree that Echosens collects and uses my data in accordance with the Privacy Policy.
URL
This field is for validation purposes and should be left unchanged.

Catégorie: Press Release

Echosens and Novo Nordisk Advance Partnership to Increase Awareness and Early Diagnosis of MASH

Echosens and United Digestive Partner to Expand Access to Non-Invasive Liver Diagnostics

Echosens and Boehringer Ingelheim Expand Long-Standing Collaboration to Accelerate Progress in MASH Diagnosis and Care

Echosens Launches its LHM Platform Globally, Streamlining Liver Care

Meet the Inaugural Echosens Liver Health Super Shaper Award Recipients

Echosens Announces the Liver Health Super Shaper Award to Honor Exceptional Medical Heroes

Transforming Liver Health: Echosens Next-Generation FibroScan^® Now Available Worldwide

Welcome Prof. Victor de Lédinghen MD PhD, Our New Chief Medical Officer at Echosens

FDA Expands Indications for Use of FibroScan^® for Comprehensive Liver Management

New AASLD Practice Guidance Calls for the Use of Noninvasive Liver Evaluations for Earlier Detection of NAFLD and NASH

Always be informed about liver health

Catégorie: Press Release

Echosens and Novo Nordisk Advance Partnership to Increase Awareness and Early Diagnosis of MASH

Echosens and United Digestive Partner to Expand Access to Non-Invasive Liver Diagnostics

Echosens and Boehringer Ingelheim Expand Long-Standing Collaboration to Accelerate Progress in MASH Diagnosis and Care

Echosens Launches its LHM Platform Globally, Streamlining Liver Care

Meet the Inaugural Echosens Liver Health Super Shaper Award Recipients

Echosens Announces the Liver Health Super Shaper Award to Honor Exceptional Medical Heroes

Transforming Liver Health: Echosens Next-Generation FibroScan® Now Available Worldwide

Welcome Prof. Victor de Lédinghen MD PhD, Our New Chief Medical Officer at Echosens

FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management

New AASLD Practice Guidance Calls for the Use of Noninvasive Liver Evaluations for Earlier Detection of NAFLD and NASH

Always be informed about liver health

Transforming Liver Health: Echosens Next-Generation FibroScan^® Now Available Worldwide

FDA Expands Indications for Use of FibroScan^® for Comprehensive Liver Management